mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.16 |
0.01 |
mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |
mRNA |
RAF265 |
FIMM |
pan-cancer |
AAC |
-0.53 |
0.02 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.02 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |